Biolife solutions acquires panthera cryosolutions to advance leadership as a pure play bioproduction consumables company

Strategic acquisition enhances biopreservation media portfolio with novel ice recrystallization inhibitor technology marks the second acquisition from bioproduction innovation accelerator program bothell, wash. , april 7, 2025 /prnewswire/ --  biolife solutions , inc. (nasdaq: blfs ) ("biolife" or the "company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("cgt") market, today announced the acquisition of privately-held panthera cryosolutions, inc., ("panthera"), a developer of novel cryopreservation solutions based on proprietary ice recrystallization inhibitor ("iri") technology.
BLFS Ratings Summary
BLFS Quant Ranking